Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Unravelling the Invisible Infiltrating Component of Glioblastoma Using MRI and a Strong Iron-like Bloodpool Contrast Medium?

NCT05656300 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT05656300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05656300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Unravelling the Invisible Infiltrating Component of Glioblastoma Using MRI and a Strong Iron-like Bloodpool Contrast Medium?
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2023
Completion date
April 1, 2025
Enrollment
15 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma